Ductal carcinoma in Situ

Slide 1 · Ductal carcinoma in situ

Pathology of an in situ breast epithelial neoplasm

Anatomic boundary • molecular pathways • morphology

Mammographic detection • clinicopathologic consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · What this lecture should establish

Define DCIS using epithelial confinement and basement-membrane integrity.

Interpret nuclear grade, architectural pattern, necrosis, and calcification.

Connect molecular phenotype to progression risk and local management.

Slide 3 · Carcinoma in situ: The defining boundary

Schematic — not a histologic specimen

Neoplastic epithelial cells remain confined within duct–lobular structures.

The basement membrane separates the proliferation from adjacent stroma.

Crossing this boundary defines stromal invasion, not the degree of cytologic atypia.

Slide 4 · DCIS arises in the terminal duct–lobular system

Terminal duct–lobular unit

In situ epithelial proliferation

Ductal/lobular compartment expansion

Ducts and lobules form a connected anatomic epithelial compartment.

Slide 5 · Why “ductal” is not a cell-of-origin label

Historic terminology

• Ductal and lobular labels originally reflected involved-space appearance.

• Both major breast carcinoma groups are thought to originate in terminal duct–lobular units.

Contemporary meaning

• Patterns reflect distinctive tumor genetics and biology.

• The term DCIS describes a clinicopathologic phenotype, not a uniquely duct-derived progenitor.

Slide 6 · DCIS: Epithelial proliferation with preserved containment

Schematic — not a histologic specimen

Ducts and lobules are expanded by neoplastic epithelial cells.

Myoepithelial cells are generally preserved along the involved spaces.

No unequivocal tumor nests are seen beyond the basement membrane.

Slide 7 · In situ disease versus invasive carcinoma

DCIS

• Malignant epithelial cells remain within duct–lobular boundaries.

• The myoepithelial compartment is generally preserved.

Invasive carcinoma

• Malignant cells infiltrate the surrounding breast stroma.

• Loss/disruption of the normal duct boundary must be assessed.

Slide 8 · A boundary-based view of progression

Schematic — not a histologic specimen

DCIS and invasive cancer can share many molecular changes.

Acquiring morphologic invasion is a separate step from acquiring cytologic malignancy.

The mechanisms permitting escape into stroma are incompletely understood.

Slide 9 · Ductal spread explains extensive DCIS

Intraductal expansion along branching ducts

DCIS may spread along a connected ductal network.

A single lesion can involve a large segment of breast tissue.

Segmental extent is not reliably inferred from a small core biopsy.

Slide 10 · Why DCIS is often clinically occult

DCIS usually produces no distinct gross mass.

Detection often relies on screening mammography rather than palpation.

A positive core biopsy does not establish the full breast extent.

Slide 11 · Mammographic calcification is the common clue

Intraluminal change

Calcified material

Mammographic abnormality

Tissue sampling

Radiologic calcium localizes lesions; Histology establishes their nature.

Slide 12 · Two morphologic sources of calcification

Central necrotic material can calcify, especially in high-grade lesions.

Secretory products may calcify in low-grade architectural patterns.

Calcification supports localization but does not by itself determine histologic grade.

Slide 13 · Calcification does not imply one DCIS phenotype

High-grade association

• Comedo necrosis can create central ductal calcium deposits.

• Specimen imaging may show linear or branching calcifications.

Low-grade association

• Cribriform spaces may contain calcifying secretory material.

• Calcification may occur without destructive central necrosis.

Slide 14 · When DCIS appears as a mammographic density

Periductal fibrosis may produce a density or vague palpable mass.

The density reflects a stromal response adjacent to an in situ lesion.

A density does not independently prove stromal invasion.

Slide 15 · Uncommon modes of presentation

Nipple discharge

• Uncommon presentation; Often linked to micropapillary/papillary types.

• The discharge warrants ductal and clinical correlation.

Incidental detection

• DCIS may be discovered during biopsy of another lesion.

• Diagnosis rests on microscopic architecture and containment.

Slide 16 · Image–pathology correlation as a diagnostic sequence

Imaging abnormality

Representative tissue

Pattern and nuclear grade

Assess invasion and extent

Sampling and microscopic assessment complement the imaging finding.

Slide 17 · Why sampling is central to interpretation

The radiographic target may contain calcified necrosis or secretions.

Microscopic examination is necessary to classify the epithelial proliferation.

Sampling may fail to capture a separate small invasive focus.

Slide 18 · Nuclear grade governs DCIS classification

Nuclear size

Nuclear shape / pleomorphism

Overall nuclear grade

The final grade reflects nuclear morphology, not a growth pattern.

Slide 19 · Grade and architecture are different dimensions

Nuclear grade

• Assessed from cytologic nuclear features.

• Robbins separates low- and high-grade biological pathways.

Architecture

• Describes the arrangement of epithelial growth.

• Cribriform, micropapillary and papillary patterns are examples.

Slide 20 · Low-grade DCIS: Relatively uniform cytology

Schematic — not a histologic specimen

Nuclear uniformity supports a low-grade interpretation.

An involved duct may show orderly cribriform luminal fenestrations.

Low-grade biology is frequently associated with ER positivity.

Slide 21 · High-grade DCIS: Pronounced nuclear atypia

Schematic — not a histologic specimen

High-grade lesions show greater nuclear abnormality.

Comedo-type central necrosis is often associated with high-grade DCIS.

Some lesions show marked calcification within necrotic ducts.

Slide 22 · Low-grade and high-grade DCIS at a glance

Feature

Low grade

High grade

Nuclei

More uniform

More pleomorphic

ER expression

Typically positive

May be negative

HER2 expression

Typically negative

May be positive

Molecular context

16q loss / 1q gain

Genomic instability / varied changes

Central comedo necrosis

Not defining

Common association

Slide 23 · Comedo necrosis: Central death within filled ducts

Schematic — not a histologic specimen

Necrotic debris occupies the center of the expanded duct.

DCIS remains in situ if the surrounding basement membrane is intact.

Necrosis and calcification are separable but often linked findings.

Slide 24 · A plausible route to visible calcification

Ductal epithelial filling

Central degeneration / secretion

Local calcium deposition

Imaging visibility

Calcification can follow necrosis or accumulation of secretory products.

Slide 25 · Cribriform architecture: Punched-out lumina

Schematic — not a histologic specimen

Multiple rounded regular spaces interrupt the epithelial proliferation.

The lumina may contain secretions or calcified material.

Cribriform pattern is architectural; Nuclear grade still requires separate assessment.

Slide 26 · Micropapillary architecture: Projections without cores

Schematic — not a histologic specimen

Bulbous epithelial tufts project into ductal lumina.

These tufts lack a fibrovascular stalk.

Micropapillary architecture can be associated with nipple discharge.

Slide 27 · Papillary architecture: True fibrovascular cores

Schematic — not a histologic specimen

Papillary structures contain a genuine fibrovascular core.

Absent myoepithelial lining along neoplastic papillae.

The outer myoepithelial layer of the involved duct generally remains preserved.

Slide 28 · Cribriform, micropapillary, and papillary patterns

Pattern

Principal architectural criterion

Important distinction

Cribriform

Round “cookie-cutter” lumina

Internal fenestrations

Micropapillary

Bulbous epithelial tufts

No fibrovascular core

Papillary

Papillae with fibrovascular cores

True stalks; Papillary myoepithelial cells absent

Slide 29 · Papillary versus micropapillary DCIS

Micropapillary

• Tufts are supported by epithelial attachment to a duct wall.

• No vascularized connective-tissue core inside projections.

Papillary

• Fibrovascular stalks form branching supports.

• Outer ductal containment still determines whether the process is in situ.

Slide 30 · Necrosis is not synonymous with invasion

What necrosis tells us

• Cell death occurs within the tumor-filled duct.

• Can accompany high-grade DCIS and calcification.

What necrosis does not tell us

• Cannot prove penetration of basement membrane.

• Does not replace examination of peripheral ductal boundaries.

Slide 31 · Reading an involved duct from outside inward

Schematic — not a histologic specimen

First identify stroma and the ductal boundary.

Then evaluate the myoepithelial layer and luminal proliferation.

Finally grade nuclei and describe pattern, necrosis, and calcification.

Slide 32 · The low-grade breast neoplasia pathway

Low-grade pathway

Low-grade DCIS / LCIS

Low-grade invasive carcinoma

Low- and high-grade carcinomas are biologically divergent pathways.

Slide 33 · Low-grade DCIS: Characteristic molecular profile

Typically expresses estrogen receptor (ER).

Typically lacks HER2 overexpression in the Robbins description.

Common chromosomal alterations include loss of 16q and gain of 1q.

Slide 34 · Recognizable low-grade precursor continuum

Columnar cell lesion

Flat epithelial atypia

Atypical ductal hyperplasia

Low-grade DCIS

Conceptual continuum: Progression is neither inevitable nor strictly linear.

Slide 35 · Low-grade lesions share a clonal background

Earlier precursor lesions and low-grade DCIS show overlapping molecular changes.

Low-grade DCIS may resemble atypical ductal hyperplasia architecturally.

The morphologic boundary between ADH and DCIS often depends on extent.

Slide 36 · The high-grade pathway has a different starting point

Early precursor not defined

High-grade DCIS

High-grade invasive carcinoma

The earliest recognizable high-grade precursor remains undefined.

Slide 37 · High-grade DCIS: Instability and heterogeneity

ER may be negative, and HER2 may be positive.

The genome can exhibit abnormalities shared with high-grade invasive tumors.

13q loss, 11q13 gain and 17q12 amplification as high-grade-pathway examples.

Slide 38 · Grade-associated profiles are tendencies, not rules

Question

Interpretation

ER-positive?

Common in low-grade DCIS; Not proof of low grade by itself

HER2-positive?

May occur in high-grade DCIS; Not a substitute for nuclear grading

16q loss / 1q gain?

Support the low-grade molecular pathway

Genomic instability?

Characteristic of the high-grade pathway

Architecture?

Neither receptor status nor pattern replaces nuclear-grade assessment

Slide 39 · Tumor genetics do not fully explain invasion

Genomic observation

• Many driver alterations exist before invasion.

• No universal invasion-specific genetic change has been identified in the cited chapter.

Mechanistic implication

• Tumor–microenvironment interactions may influence transition.

• The precise cause of invasion remains incompletely resolved.

Slide 40 · Potential stromal contribution to invasion

Myoepithelial alterations

Basement-membrane disruption

Permissive stromal milieu

Stromal infiltration

Proposed mechanism, not a clinically established deterministic sequence.

Slide 41 · Microenvironmental hypotheses: Interpret cautiously

Myoepithelial cells, stromal cells and extracellular matrix help maintain the duct barrier.

Some in situ cancers show attenuation of the myoepithelium or gaps in basement membrane.

These observations suggest mechanisms; They are not a deterministic clinical algorithm.

Slide 42 · Spatial extent and biology are independent concerns

Intraductal expansion along branching ducts

A low-grade process may occupy a broad ductal network.

A high-grade focus may be relatively localized in a sampled region.

Both the biologic grade and anatomic extent affect clinical decisions.

Slide 43 · Paget disease: Intraductal-to-epidermal spread

DCIS in lactiferous ducts

Spread through lactiferous sinuses

Paget cells in nipple epidermis

Surface disruption

Epidermal extension can occur without crossing a basement membrane.

Slide 44 · Paget disease: Characteristic presentation

Rare breast cancer manifestation (1%–4% of cases).

Typically unilateral, erythematous and scaly/crusted.

Pruritus can lead to an initial impression of eczema.

Slide 45 · Why Paget disease produces an oozing crust

Nipple epidermis

Lactiferous duct

Schematic — not a histologic specimen

Neoplastic cells extend into nipple epidermis without stromal invasion by that route.

Paget cells disrupt the squamous epithelial barrier.

Extracellular fluid reaches the surface, contributing to scale and crust.

Slide 46 · Paget disease: With and without a palpable mass

No palpable breast mass

• Most patients have underlying DCIS.

• Staging usually reflects the underlying in situ process.

Palpable breast mass

• About half of patients have a detectable mass.

• The mass usually represents invasive carcinoma.

Slide 47 · Paget disease: Microscopic confirmation

Paget cells can be detected in nipple biopsy tissue.

Cytologic preparations of nipple exudate may reveal malignant cells.

The underlying breast lesion must be assessed for a separate invasive component.

Slide 48 · Paget disease and dermatitis: A diagnostic trap

Possible clinical overlap

• Erythema, scale, crust and pruritus are nonspecific on appearance.

• A unilateral persistent nipple lesion deserves tissue evaluation.

Pathologic discriminator

• Malignant intraepidermal Paget cells establish neoplastic involvement.

• Assess for ductal DCIS and associated invasion, when present.

Slide 49 · Why the untreated natural history is uncertain

Most DCIS is treated shortly after detection.

Observed progression therefore reflects selected untreated or residual disease.

Rates from limited natural-history observations cannot be generalized to every grade and extent.

Slide 50 · Progression in small, low-grade DCIS

An invasive-cancer development rate near 1% per year.

This estimate concerns small, low-grade lesions in the available data.

It is not a prediction for an individual patient or for high-grade DCIS.

Slide 51 · Concordance between DCIS and later invasive disease

Existing in situ clone

Subsequent same-quadrant invasion

Often similar grade and ER/HER2 profile

Concordant grade and receptor expression support a related lineage.

Slide 52 · High-grade and extensive DCIS: Greater concern

High-grade disease is believed to progress more rapidly.

Extensive disease carries a higher estimated risk of later invasion.

The source frames this as inference from incomplete natural-history data.

Slide 53 · Metastatic breast cancer after a DCIS diagnosis

Metastatic death in approximately 1%–3% after DCIS diagnosis.

Possible origins include later invasive tumors in either breast.

Occult invasion missed at the original diagnosis is another possible explanation.

Slide 54 · Population survival must not be misread causally

Textbook observation

• Overall mortality among US females with diagnosed DCIS is lower than population mortality.

• The source discusses screening and care-access differences.

What cannot be concluded

• DCIS is not protective against death.

• The observation does not prove that DCIS treatment improves all-cause longevity.

Slide 55 · Why definitive extent assessment is difficult

DCIS is commonly inapparent on gross inspection at surgery.

Distribution may not correspond exactly to mammographic calcifications.

Pathologic examination of the excision and margins is therefore critical.

Slide 56 · Three major recurrence-risk features

Risk feature

Pathologic explanation

High grade and necrosis

More aggressive lesion biology

Extensive DCIS

Greater anatomic field of disease

Positive surgical margins

Potential residual neoplastic epithelium remains

Slide 57 · Local treatment targets persistence or recurrence

DCIS diagnosis

Complete local excision

Margin assessment

Consider adjuvant risk reduction

Excision extent and margin status inform residual local disease risk.

Slide 58 · Mastectomy is highly effective for DCIS

Cure in more than 95% of patients.

Local treatment is rational because DCIS is confined to breast duct–lobular units.

Occult invasive disease and later contralateral cancers explain why risk never becomes absolutely zero.

Slide 59 · Radiation reduces local recurrence after surgery

Postoperative radiation is described as reducing recurrence risk.

Its contribution concerns local disease control, not proof of preexisting invasion.

The source excerpt does not supply a patient-level indication rule or effect size.

Slide 60 · Endocrine risk reduction with tamoxifen

Tamoxifen reduces recurrence clinical discussion.

This is especially biologically relevant to ER-expressing neoplastic epithelium.

The source does not define a complete contemporary endocrine-treatment algorithm.

Slide 61 · Surveillance trials versus established local treatment

Current textbook account

• Trials are ongoing to identify DCIS subgroups safe for observation.

• Progression estimates are heterogeneous and uncertain.

Teaching interpretation

• Do not equate indolent biology with guaranteed harmlessness.

• Do not present observation as universally proven equivalent to excision.

Slide 62 · DCIS versus lobular carcinoma in situ

Feature

DCIS

Classic LCIS

Imaging

Usually calcification-associated

Often incidental finding

Cell growth

Cohesive architectural patterns

Dyscohesive cells

E-cadherin

Usually retained in ductal phenotype

Usually lost

Clinical orientation

Local ipsilateral recurrence/precursor

Risk to either breast

Slide 63 · Atypical ductal hyperplasia versus DCIS

Shared features

• Uniform cells with cribriform or micropapillary pattern.

• Both belong to the low-grade neoplasia pathway.

Distinguishing consideration

• ADH is limited in size and extent.

• More extensive proliferation with characteristic features supports DCIS.

Slide 64 · Common interpretive errors in DCIS

Calling an architectural pattern a histologic grade.

Mistaking central necrosis for proof of stromal invasion.

Assuming the full lesion extent can be read from one core sample.

Slide 65 · Case study: Calcifications with punched-out lumina

Clinical–pathology scenario

• Screening mammography prompts biopsy of segmental calcifications.

• Ducts contain relatively uniform epithelial cells and round fenestrations.

What pattern is present, and which separate feature still requires grading?

Slide 66 · Case analysis: Cribriform DCIS

Mechanism-based interpretation

Cribriform pattern is identified by regular round intratumoral spaces.

Assign nuclear grade by nuclear features, not by naming the pattern.

Determine absence or presence of invasion separately.

Slide 67 · Case study: Unilateral scaly nipple change

Clinical–pathology scenario

• A patient develops pruritic unilateral scaling and crusting of the nipple.

• A biopsy identifies malignant epithelial cells in the epidermis.

What ductal route is possible, and what underlying lesion must be assessed?

Slide 68 · Case analysis: Paget disease

Mechanism-based interpretation

DCIS may extend through lactiferous ducts into nipple epidermis.

Paget cells impair epithelial barrier function and cause crusting.

Assess underlying breast tissue for DCIS versus an associated invasive mass.

Slide 69 · Case study: A focal excision with positive margin

Clinical–pathology scenario

• An excision contains high-grade DCIS with comedo necrosis.

• The epithelial proliferation reaches the inked resection margin.

Which independent features increase concern for subsequent recurrence?

Slide 70 · Case analysis: Recurrence-risk assessment

Mechanism-based interpretation

High nuclear grade and necrosis are major adverse factors.

Positive margin suggests possible residual disease after excision.

Overall disease extent remains another critical variable.

Slide 71 · Synthesis: Six durable concepts

DCIS is malignant epithelial proliferation without demonstrable stromal invasion.

Mammographic calcification often reveals otherwise occult disease.

Grade is primarily nuclear; Architecture is a separate descriptor.

Low- and high-grade DCIS follow biologically different pathways.

Paget disease may reflect epidermal extension of an underlying DCIS.

Risk assessment depends on grade, necrosis, extent and margins.

Slide 72 · Source and interpretation boundaries

Primary teaching source: Robbins, Cotran & Kumar, Pathologic Basis of Disease, 11th edition.

Chapter 23: The Breast — carcinoma in situ, precursor lesions, and breast-cancer pathogenesis.

All histology-like drawings in this lecture are editable conceptual schematics; no diagnostic specimen images were embedded.

Scope: Robbins text and parent context; no external treatment guidelines incorporated.